Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Flagstar Bank NA (FLG) vs Johnson & Johnson (JNJ) Price & Performance

Flagstar Bank NATrade
Johnson & JohnsonTrade

Price performance (Past 24H)

Key statistics

Flagstar Bank NA vs Johnson & Johnson — how do they compare? Flagstar Bank NA trades at $14.2 (market cap $5.89B), while Johnson & Johnson trades at $260.79 (market cap $626.09B). The key difference: Johnson & Johnson is far larger — about 106.3× Flagstar Bank NA's market cap, and Johnson & Johnson pays the higher dividend (2.06%). Which is the better fit depends on your goals.

FLGJNJ
Market Cap
$5.89B$626.09B
Sector
FinancialsHealth
52-Week High
$15.36$267.24
52-Week Low
$10.72$172.78
Dividend Yield
0.28%2.06%
Volume
6,156,228
Enterprise Value
$654.37B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Flagstar Bank NA

FLG trades at $14.20, up 1.36% today, with a bullish technical signal and analyst consensus price target of $16.85 suggesting 19% upside. Recent Q2 2026 earnings missed estimates, but the bank reported its third consecutive profitable quarter, supported by loan growth and cost controls. A $250 million share repurchase program and strategic operational enhancements signal management confidence in long-term value.

The outlook is cautiously optimistic, with profitability improving and valuation attractive at a P/B of 0.77. Risks include earnings volatility, competitive pressures, and economic sensitivity. Institutional sentiment leans bullish, with no sell ratings, though execution on guidance remains key for sustained momentum.

Johnson & Johnson

Johnson & Johnson (JNJ) trades at $261.26, down 0.21% on the day, near its 52-week high. The stock shows a bullish technical trend with strong moving averages and recent earnings beats. Revenue grew to $94.19B in 2025, with a net income margin of 21.48%, though cash flow turned negative due to heavy investing. The company maintains a robust dividend history, with consistent payouts and a 64-year growth streak.

Outlook remains positive with a consensus price target of $284.50, offering ~9% upside. Risks include legal headwinds and patent expirations, but analyst sentiment is bullish (52.5% buy ratings). JNJ's defensive profile and pipeline strength support long-term growth, though investors should monitor debt levels, which rose to 24.06% of assets in 2025.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Flagstar Bank NA

Flagstar Bank is a prominent US financial institution and a subsidiary of New York Community Bancorp. It provides commercial banking, mortgage services, and diverse personal finance products.

Read more on FLG

About Johnson & Johnson

Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.

Read more on JNJ